Cite
HARVARD Citation
Li, T. et al. (2022). Semimechanistic Physiologically‐Based Pharmacokinetic/Pharmacodynamic Model Informing Epcoritamab Dose Selection for Patients With B‐Cell Lymphomas. Clinical pharmacology & therapeutics. 112 (5), pp. 1108-1119. [Online].